Edition:
United Kingdom

People: Credit Suisse Group AG (CSGN.S)

CSGN.S on Virt-X Level 1

13.10CHF
13 Sep 2019
Change (% chg)

CHF0.27 (+2.10%)
Prev Close
CHF12.83
Open
CHF12.94
Day's High
CHF13.21
Day's Low
CHF12.94
Volume
19,515,033
Avg. Vol
11,998,609
52-wk High
CHF15.44
52-wk Low
CHF10.36

Schwan, Severin 

Dr. Severin Schwan has been Non-Executive Independent Vice Chairman of the Board, Lead Independent Director at Credit Suisse Group Ltd since 2017. He was Independent Member of the Board of Directors of Credit Suisse Group Ltd from 2014. He is Member of the Governance and Nominations Committee (2017–present) and Member of the Risk Committee (2014–present) and was Member of the board of Credit Suisse (Schweiz) AG (Swiss subsidiary) (2015 – 2017). He has served at Roche Group as CEO (2008–present), Member of the board of Roche Holding Ltd. (2013–present), CEO, Division Roche Diagnostics (2006 – 2008), Head Asia Pacific Region, Roche Diagnostics Singapore (2004 – 2006), Head Global Finance & Services, Roche Diagnostics Basel (2000 – 2004), and held various management and other positions with Roche Germany, Belgium and Switzerland (1993 – 2000). He holds Master’s degrees in Economics and Law from University of Innsbruck and a Doctor of Law degree from University of Innsbruck.

Basic Compensation

Total Annual Compensation, CHF 400,000
Restricted Stock Award, CHF --
Long-Term Incentive Plans, CHF --
All Other, CHF --
Fiscal Year Total, CHF 400,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --